| 期刊全称 | Immunopharmacology and Immunotoxicology | |||||||||||||||||||||||||||||||||||||||
| 期刊缩写 | Immunopharmacol. Immunotoxicol. | |||||||||||||||||||||||||||||||||||||||
|
涉及主题
（科研通AI识别） |
||||||||||||||||||||||||||||||||||||||||
| 期刊介绍 | The journal Immunopharmacology and Immunotoxicology is devoted to pre-clinical and clinical drug discovery and development targeting the immune system. Research related to the immunoregulatory effects of various compounds, including small-molecule drugs and biologics, on immunocompetent cells and immune responses, as well as the immunotoxicity exerted by xenobiotics and drugs. Only research that describe the mechanisms of specific compounds (not extracts) is of interest to the journal. The journal will prioritise preclinical and clinical studies on immunotherapy of disorders such as chronic inflammation, allergy, autoimmunity, cancer etc. The effects of small-drugs, vaccines and biologics against central immunological targets as well as cell-based therapy, including dendritic cell therapy, T cell adoptive transfer and stem cell therapy, are topics of particular interest. Publications pointing towards potential new drug targets within the immune system or novel technology for immunopharmacological drug development are also welcome. With an immunoscience focus on drug development, immunotherapy and toxicology, the journal will cover areas such as infection, allergy, inflammation, tumor immunology, degenerative disorders, immunodeficiencies, neurology, atherosclerosis and more. Immunopharmacology and Immunotoxicology will accept original manuscripts, brief communications, commentaries, mini-reviews, reviews, clinical trials and clinical cases, on the condition that the results reported are based on original, clinical, or basic research that has not been published elsewhere in any journal in any language (except in abstract form relating to paper communicated to scientific meetings and symposiums). | |||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||
| 期刊ISSN | print: 0892-3973on-line: 1532-2513 | |||||||||||||||||||||||||||||||||||||||
| 2026最新影响因子 (2026年6月17日发布) 与上一年的差值 |
3.1↑ 0.1 | |||||||||||||||||||||||||||||||||||||||
| 历年影响因子 |
|
|||||||||||||||||||||||||||||||||||||||
| 历年发表/被引量 （科研通AI通过大数据分析） 最后更新日期：2026-07-16 |
|
|||||||||||||||||||||||||||||||||||||||
| h-index（2021） | 42 | |||||||||||||||||||||||||||||||||||||||
| 自引率 | 0.00% | |||||||||||||||||||||||||||||||||||||||
| 涉及的研究领域 | 医学-毒理学 | |||||||||||||||||||||||||||||||||||||||
| 2026年新锐分区 （2026年3月24日发布） |
|
|||||||||||||||||||||||||||||||||||||||
| 2026年WOS期刊分区 （2026年6月17日发布） |
JCR学科分类
JCI学科分类
|
|||||||||||||||||||||||||||||||||||||||
| 中科院2025年分区 （2025年3月20日发布） |
|
|||||||||||||||||||||||||||||||||||||||
| 中科院2024年分区 （2023年12月27日发布） |
|
|||||||||||||||||||||||||||||||||||||||
| 中科院《国际期刊预警名单（试行）》名单 |
2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2021年01月发布的2020版：不在预警名单中 |
|||||||||||||||||||||||||||||||||||||||
| 期刊主页 | ||||||||||||||||||||||||||||||||||||||||
| 投稿网址 | http://mc.manuscriptcentral.com/lipi | |||||||||||||||||||||||||||||||||||||||
| 编辑部地址 | TAYLOR & FRANCIS INC, 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, USA, PA, 19106 | |||||||||||||||||||||||||||||||||||||||
| 出版商 | Informa Healthcare | |||||||||||||||||||||||||||||||||||||||
| 出版国家（地区） | UNITED STATES | |||||||||||||||||||||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||||||||||||||||||||
| 出版周期 | Quarterly | |||||||||||||||||||||||||||||||||||||||
| 每年出版文章数 | 90 | |||||||||||||||||||||||||||||||||||||||
| Gold OA文章占比 | 1.83% | |||||||||||||||||||||||||||||||||||||||
| 原创研究文献占比 （排除综述） |
92.48% | |||||||||||||||||||||||||||||||||||||||
| SCI收录类型 |
Science Citation Index Expanded (SCIE) Scopus (CiteScore) |
|||||||||||||||||||||||||||||||||||||||
| PubMed链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0892-3973%5BISSN%5D | |||||||||||||||||||||||||||||||||||||||
| 平均审稿周期 | 网友分享经验： 偏慢,4-8周 |
|||||||||||||||||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 容易 |
|||||||||||||||||||||||||||||||||||||||
| 相关链接 |
您可以在上述网站查看该期刊的网友互动，及期刊影响力的其它指标。
|
|||||||||||||||||||||||||||||||||||||||
皖公网安备34019202002308
